dr. hope rugo: adc's current clinical evidence
Published 1 year ago • 92 plays • Length 24:23Download video MP4
Download video MP3
Similar videos
-
3:37:30
the 2023 oncoalert colloquium (breast cancer)
-
3:21:26
the 2022 oncoalert colloquium day 1: breast cancer
-
35:27
dr. hope rugo – esmo 2022 – exploring the latest trial data & advances in breast cancer treatments
-
2:58:58
the oncoalert colloquium day 3 breast cancer
-
2:58:57
the oncoalert colloquium day 3 breast cancer
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
2:36:22
the oncoalert colloquium day 3 (breast cancer)
-
5:17
hope after glioblastoma diagnosis
-
57:10
breast cancer tumor boards video
-
5:23
recurrence of head and neck cancer
-
2:15:21
the oncoalert colloquium day one (gi cancers & mascc session)
-
1:15
dr. rugo discusses the future of angiogenesis in breast cancer
-
0:55
dr. rugo on the future of extended adjuvant hormone therapy for breast cancer
-
0:56
dr. rugo on proliferation as an anti-angiogenesis marker
-
2:11
dr. rugo on the standard for front-line chemotherapy
-
4:15
hope rugo, md, fasco at #asco23
-
1:53
dr. hope rugo examines angiogenesis inhibition for advanced breast cancer
-
1:00:31
inspired | beyond the white coat with dr. hope rugo
-
1:39
dr. rugo on anti-angiogenesis therapy response predictors
-
1:20
dr. rugo on hormone therapy for patients with breast cancer
-
1:33
dr. hope rugo on the first-line superiority of paclitaxel for advanced breast cancer
-
2:04
oncoalert oncologist dr. evandro de azambuja discusses the kaitlin trial presented at #asco20